Skip to main content
Clinical Trials/NCT05772026
NCT05772026
Not yet recruiting
Not Applicable

Serum Biomarkers for Postoperative Delirium Based on Plasma Proteomic Analysis of Elder Patients Undergoing Cardiac Surgery

Xuzhou Central Hospital0 sites200 target enrollmentMarch 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Delirium
Sponsor
Xuzhou Central Hospital
Enrollment
200
Primary Endpoint
Differences of Quantitative Proteomics between POD and non-POD after surgery
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Patients undergoing cardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. . Plasma was isolated from peripheral blood for subsequent proteomic analysis.

Detailed Description

Patients undergoing noncardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. Plasma was isolated from peripheral blood for subsequent proteomic analysis. To study the characteristics of proteins on a large scale, including protein expression levels, post-translational modifications, protein-protein interactions, etc., so as to obtain a comprehensive understanding of disease occurrence, cell metabolism and other processes at the protein level. Assessment of imbalanced protein expression in peripheral blood using protein profiling may allow us to better understand the pathological changes occurring at the molecular level of POD. Early detection of patients at high risk of POD can optimize perioperative management and promote rapid postoperative recovery.

Registry
clinicaltrials.gov
Start Date
March 20, 2023
End Date
January 1, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Xuzhou Central Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥65 years old, regardless of gender.
  • The patient had clear consciousness and no cognitive impairment, and could cooperate with the investigation and follow-up.
  • The ASA classification is I-Ⅲ.

Exclusion Criteria

  • severe neurological or psychiatric disorders.
  • drug and alcohol abuse.
  • Patients with cognitive impairment caused by various reasons such as neuropsychiatric symptoms.
  • Exclusion criteria included incomplete medical records and failure to complete the postoperative follow-up.

Outcomes

Primary Outcomes

Differences of Quantitative Proteomics between POD and non-POD after surgery

Time Frame: 2 day after surgery

Plasma was isolated from peripheral blood for subsequent proteomic analysis. Investigators study the characteristics of proteins at a large-scale level.

Differences of Quantitative Proteomics between POD and non-POD

Time Frame: 1 day before surgery

Plasma was isolated from peripheral blood for subsequent proteomic analysis. Investigators study the characteristics of proteins at a large-scale level.

Similar Trials